T. Rowe Price discloses 9% TechnipFMC (NYSE: FTI) holding
Rhea-AI Filing Summary
T. Rowe Price Associates, Inc. has filed an amended Schedule 13G reporting a significant passive ownership stake in TechnipFMC plc common stock. As of 12/31/2025, it reports beneficial ownership of 36,302,889 shares, representing 9.0% of the outstanding common shares.
The firm reports sole voting power over most of these shares and sole dispositive power over substantially all of them, with no shared voting or dispositive authority. It certifies that the position is held in the ordinary course of business and not for the purpose of changing or influencing control of TechnipFMC.
Positive
- None.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does T. Rowe Price report in its Schedule 13G/A for TechnipFMC (FTI)?
T. Rowe Price Associates, Inc. reports a sizable passive stake in TechnipFMC. The filing shows beneficial ownership of 36,302,889 shares of common stock, equal to 9.0% of the class, as of December 31, 2025, under a Schedule 13G/A.
What percentage of TechnipFMC (FTI) does T. Rowe Price hold according to the filing?
The filing states that T. Rowe Price holds 9.0% of TechnipFMC’s common stock. This percentage of class is reported in Item 4(b), based on 36,302,889 shares beneficially owned as of the December 31, 2025 measurement date.
Does T. Rowe Price aim to influence control of TechnipFMC (FTI)?
The filing states the position is not intended to influence TechnipFMC’s control. T. Rowe Price certifies the securities were acquired and are held in the ordinary course of business, not for changing or influencing control of the issuer.
Is T. Rowe Price’s TechnipFMC (FTI) stake held on a passive basis?
Yes, the Schedule 13G/A characterizes T. Rowe Price’s stake as passive. The certification section explains that the securities are held in the ordinary course of business and not in connection with any transaction aimed at changing or influencing control.